Denali Advisors LLC Uro Gen Pharma Ltd. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$8.84 - $22.64 $41,548 - $106,408	-4,700 Reduced 24.74%	14,300 $200,000
Q2 2023 Jul 18, 2023	BUY	$8.75 - $14.29 $166,250 - $271,510	19,000 New	19,000 $196,000
Q2 2022 Jul 18, 2022	SELL	$5.12 - $8.74 $20,992 - $35,834	-4,100 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$5.92 - $9.73 $24,272 - $39,893	4,100 New	4,100 $35,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.